Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

NVS – Novartis AG

Novartis AG
NVS
$106.61
Name : Novartis AG
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $210,564,349,952.00
EPSttm : 5.87
finviz dynamic chart for NVS
Novartis AG
$106.61
5.03%
$5.65

Float Short %

0.21

Margin Of Safety %

5

Put/Call OI Ratio

1

EPS Next Q Diff

0.26

EPS Last/This Y

2.51

EPS This/Next Y

0.3

Price

112.26

Target Price

115.87

Analyst Recom

2.96

Performance Q

15.36

Relative Volume

1.3

Beta

0.6

Ticker: NVS




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-05NVS111.881.052.3458325
2025-03-06NVS112.911.070.2858838
2025-03-07NVS115.581.080.1958703
2025-03-10NVS115.50.980.9163122
2025-03-11NVS111.451.030.0864791
2025-03-12NVS108.71.230.1461832
2025-03-13NVS109.120.960.4961773
2025-03-14NVS109.060.941.6762469
2025-03-17NVS112.240.950.4463307
2025-03-18NVS112.230.960.3163487
2025-03-19NVS111.580.960.0263526
2025-03-20NVS113.230.900.1662628
2025-03-21NVS112.120.880.0463244
2025-03-24NVS111.111.035.0648654
2025-03-25NVS110.411.090.7250500
2025-03-26NVS110.141.070.2753849
2025-03-27NVS111.411.020.3755559
2025-03-28NVS112.571.010.4555759
2025-03-31NVS111.471.000.5256382
2025-04-01NVS109.611.000.7556815
2025-04-02NVS110.761.001.4757502
2025-04-03NVS112.31.000.3358063
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-05NVS111.8614.13637.88.43
2025-03-06NVS112.9514.33496.58.45
2025-03-07NVS115.5814.33999.68.38
2025-03-10NVS115.5314.33603.38.38
2025-03-11NVS111.4114.32806.58.38
2025-03-12NVS108.7314.33951.58.38
2025-03-13NVS109.1114.33953.78.38
2025-03-14NVS109.0614.33364.38.38
2025-03-17NVS112.2214.33854.18.38
2025-03-18NVS112.2214.33520.58.38
2025-03-19NVS111.5614.33412.28.38
2025-03-20NVS113.2114.33604.78.38
2025-03-21NVS112.1214.33183.48.38
2025-03-24NVS111.0914.33355.18.38
2025-03-25NVS110.3814.33403.88.38
2025-03-26NVS110.1414.33474.48.38
2025-03-27NVS111.4214.33767.88.38
2025-03-28NVS112.5714.33705.18.38
2025-03-31NVS111.4814.33465.28.43
2025-04-01NVS109.6114.34280.98.43
2025-04-02NVS110.7714.34420.98.43
2025-04-03NVS112.2614.34965.58.43
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-05NVS06.320.20
2025-03-06NVS06.320.20
2025-03-07NVS06.320.20
2025-03-10NVS06.240.20
2025-03-11NVS06.240.20
2025-03-12NVS06.240.25
2025-03-13NVS06.240.25
2025-03-14NVS06.240.25
2025-03-17NVS06.250.25
2025-03-18NVS06.250.25
2025-03-19NVS06.250.25
2025-03-20NVS06.250.25
2025-03-21NVS06.250.25
2025-03-24NVS06.580.27
2025-03-25NVS06.580.27
2025-03-26NVS06.580.21
2025-03-27NVS06.580.21
2025-03-28NVS06.580.21
2025-03-31NVS06.080.21
2025-04-01NVS06.080.21
2025-04-02NVS06.080.21
2025-04-03NVS06.080.21
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

1.98

Avg. EPS Est. Current Quarter

2.06

Avg. EPS Est. Next Quarter

2.24

Insider Transactions

Institutional Transactions

6.08

Beta

0.6

Average Sales Estimate Current Quarter

12924

Average Sales Estimate Next Quarter

13660

Fair Value

117.46

Quality Score

96

Growth Score

78

Sentiment Score

87

Actual DrawDown %

7.2

Max Drawdown 5-Year %

-20.4

Target Price

115.87

P/E

19.11

Forward P/E

12.86

PEG

3.09

P/S

4.23

P/B

5.03

P/Free Cash Flow

13.11

EPS

5.87

Average EPS Est. Cur. Y​

8.43

EPS Next Y. (Est.)

8.73

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

23.73

Relative Volume

1.3

Return on Equity vs Sector %

7.3

Return on Equity vs Industry %

0.1

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

-0.05

EBIT Estimation

4965.5
Novartis AG
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 75883
Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with certain types of cancers; and Jakavi for the treatment of myelofibrosis, polycythemia vera, and acute or chronic graftversushost disease (GvHD). It also provides Tasigna to treat philadelphia chromosomepositive chronic myeloid leukemia in the chronic and/or accelerated phase; Xolair for the treatment of allergic asthma and nasal polyps or severe chronic rhinosi nusitis with nasal polyps; Ilaris to treat fever syndromes, Still's disease, and acute gouty arthritis; Pluvicto to treat prostatespecific membrane anti genpositive metastatic castrationresistant prostate cancer; Sandostatin SC and Sandostatin LAR to treat acromegaly carcinoid tumors and other types of functional gastro intestinal and pancreatic neuroendocrine tumors; Zolgensma for the treatment of genetic root cause of spinal muscular atrophy; Lucentis; Leqvio to reduce LDL cholesterol; Lutathera; Scemblix; and Fabhalta. The company focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, oncology, and hematology. It has a license and collaboration agreement with Alnylam Pharmaceuticals, Inc. to develop, manufacture, and commercialize Leqvio (inclisiran), a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
stock quote shares NVS – Novartis AG Stock Price stock today
news today NVS – Novartis AG stock forecast ,stock prediction 2023 2024 2025
marketwatch NVS – Novartis AG yahoo finance google finance
stock history NVS – Novartis AG invest stock market
stock prices NVS premarket after hours
ticker NVS fair value insiders trading